Proof of principle of the efficacy of IL-6 receptor blockade in severe systemic juvenile idiopathic arthritis (SJIA)

被引：0
作者：
Woo, P
Wilkinson, N
Prieur, A
Southwood, T
Leone, V
Livermore, P
Wythe, H
Thomson, D
Kishimoto, T
机构：
[1] Great Ormond St Hosp Sick Children, Rheumatol Unit, London WC1N 3JH, England
[2] Hop Necker Enfants Malad, Dept Pediat Rheumatol, Paris, France
[3] Birmingham Childrens Hosp NHS Trust, Birmingham, W Midlands, England
[4] Chugai Pharmaceut Co Ltd, London, England
[5] Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Regulat, Osaka, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
[31]   The correlations of serum interleukin-6 (il-6) levels and serum soluble il-6 receptor levels with disease activity in systemic juvenile idiopathic arthritis patients with and without tocilizumab treatment [J].
Butsabong Lerkvaleekul ;
Sirisucha Soponkanaporn ;
Soamarat Vilaiyuk .
Pediatric Rheumatology, 12 (Suppl 1)
[32]   Incidence, Risk Factors, and Outcomes of Eosinophilia on IL-1 and IL-6 Inhibitors in Systemic and Non-Systemic Juvenile Idiopathic Arthritis [J].
Wobma, Holly ;
Taylor, Maria ;
Lam, Ki Pui ;
Brown, Helene ;
Case, Siobhan ;
Chandler, Mia ;
Chang, Margaret ;
Cohen, Ezra ;
Day-Lewis, Megan ;
Halyabar, Olha ;
Hausmann, Jonathan ;
Hazen, Melissa ;
Janssen, Erin ;
Lee, Pui ;
Lo, Mindy ;
Meidan, Esra ;
Roberts, Jordan ;
Son, Mary Beth F. ;
Sundel, Robert ;
Dedeoglu, Fatma ;
Nigrovic, Peter ;
Casey, Alicia ;
Chang, Joyce ;
henderson, lauren .
ARTHRITIS & RHEUMATOLOGY, 2022, 74 :1721-1723
[33]   Eosinophilia and Exposure to IL-1 and IL-6 Blocking Biologic Medications in a Systemic Juvenile Idiopathic Arthritis Patient Cohort [J].
Dickey, Rachel ;
Dhar, Doel ;
Gangireddy, Srushti ;
Ong, Henry H. ;
Wei, Wei-Qi ;
Patrick, Anna .
ARTHRITIS & RHEUMATOLOGY, 2024, 76 :793-794
[34]   Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: Blockade of arthritis severity by soluble glycoprotein 130 [J].
Nowell, MA ;
Richards, PJ ;
Horiuchi, S ;
Yamamoto, N ;
Rose-John, S ;
Topley, N ;
Williams, AS ;
Jones, SA .
JOURNAL OF IMMUNOLOGY, 2003, 171 (06) :3202-3209
[35]   Distinct molecular and cellular aspects of systemic juvenile idiopathic arthritis (SJIA) and polyarticular (PolyJIA) [J].
Macaubas, Claudia ;
Nguyen, Khoa ;
Pan, Kuang-Hung ;
Lee, Tzielan ;
Deshpande, Chetan ;
Sandborg, Christy ;
Cohen, Stanley ;
Mellins, Elizabeth .
CLINICAL IMMUNOLOGY, 2007, 123 :S94-S95
[36]   PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF TOCILIZUMAB (TCZ) IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (sJIA). [J].
Zhang, X. ;
Morcos, P. N. ;
De Benedetti, F. ;
Brunner, H. ;
Ruperto, N. ;
Schaefer, F. ;
Roseti, S. ;
Kenwright, A. ;
Martini, A. ;
Lovell, D. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 :S36-S36
[37]   Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data [J].
F De Benedetti ;
H Brunner ;
N Ruperto ;
R Schneider ;
P Woo ;
R Burgos-Vargas ;
P Dolezalova ;
R Joos ;
N Wulffraat ;
Z Zuber ;
F Zulian ;
R Allen ;
D Brown ;
J Chaitow ;
M Pardeo ;
G Espada ;
B Flato ;
V Gerloni ;
G Horneff ;
S Wright ;
A Kenwright ;
D Lovell ;
A Martini .
Pediatric Rheumatology, 9 (Suppl 1)
[38]   Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data [J].
Fabrizio De Benedetti ;
Hermine Brunner ;
Nicola Ruperto ;
R Cuttica ;
Clara Malattia ;
Rayfel Schneider ;
Patricia Woo ;
Despina Eleftheriou ;
Eileen Baildam ;
Ruben Burgos-Vargas ;
Pavla Dolezalova ;
Stella M Garay ;
Rik Joos ;
Nico Wulffraat ;
Zbyszek Zuber ;
Francesco Zulian ;
Carine Wouters ;
Ricardo M Xavier ;
Lawrence Zemel ;
Stephen Wright ;
Andy Kenwright ;
Alberto Martini ;
Daniel Lovell .
Pediatric Rheumatology, 10 (Suppl 1)
[39]   Systemic IL-6 and Severe Asthma [J].
Lipworth, Brian ;
Chan, Rory ;
Kuo, Chris .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (09) :1324-1325
[40]   Long-term therapeutic efficacy of humanized anti-il 6-receptor antibody for systemic juvenile idiopathic arthritis. [J].
Yokota, S ;
Miyamae, TK ;
Imagawa, T ;
Nishimoto, N ;
Yoshizaki, K ;
Mori, M ;
Hirsch, R .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :S479-S479
12345